Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2951 to 3000 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1476\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01928\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.051\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon protein 3 (neuroendocrine-specific protein-like 2) (nsp-like protein ii) (nsplii). [source:swissprot;acc:o95197]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
207.013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.037\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.267\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01922\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
215.122\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.066\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 12 (trip12). [source:swissprot;acc:q14669]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
205.817\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.851\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
4.034\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1479\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.61) (e2) (e2k). [source:swissprot;acc:p36957]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maguk p55 subfamily member 6 (veli-associated maguk 1) (vam-1). [source:swissprot;acc:q9nzw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0192\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 6, 68 kd subunit; pre-mrna cleavage factor im (68kd); cleavage and polyadenylation specific factor 6, 68kd subunit; pre-mrna cleavage factor i, 68kd subunit. [source:refseq;acc:nm\_007007]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
218.664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01918\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 (ec 2.7.1.-) (transforming growth factor-beta-activated kinase 1) (tgf-beta- activated kinase 1). [source:swissprot;acc:o43318]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.987\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1481\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.971\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.516\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01915\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1482\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-centractin (actin-related protein 1b) (arp1b). [source:swissprot;acc:p42025]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.971\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.15\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0191\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1483\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component beta subunit, mitochondrial precursor (ec 1.2.4.1) (pdhe1-b). [source:swissprot;acc:p11177]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
198.927\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.726\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein 10 (rna binding motif protein 10) (dxs8237e). [source:swissprot;acc:p98175]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1484\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.927\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.726\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0191\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c. [source:swissprot;acc:p00001]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1485\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
j kappa-recombination signal binding protein (rbp-j kappa). [source:swissprot;acc:q06330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01906\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1486\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase; heparan-sulfate 6-sulfotransferase. [source:refseq;acc:nm\_004807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer binding protein 3. [source:refseq;acc:nm\_024503]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01906\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1487\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid hydroxylase domain containing 1. [source:refseq;acc:nm\_024306]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 40 (human immunodeficiency virus type i enhancer- binding protein 1) (hiv-ep1) (major histocompatibility complex binding protein 1) (mbp-1) (positive regulatory domain ii binding factor 1) (prdii-bf1). [source:swissprot;acc:p15822]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01906\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1488\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer-binding protein 2 (hiv-ep2). [source:swissprot;acc:p31629]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 11; npw38-binding protein npwbp; sh3 domain-binding protein snp70. [source:refseq;acc:nm\_016312]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1489\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elac homolog 2; putative prostate cancer susceptibility protein; elac (e. coli) homolog 2. [source:refseq;acc:nm\_018127]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 (ec 2.7.1.-) (transforming growth factor-beta-activated kinase 1) (tgf-beta- activated kinase 1). [source:swissprot;acc:o43318]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01905\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1490\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01903\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein 5 (rna binding motif protein 5) (putative tumor suppressor luca15) (g15 protein). [source:swissprot;acc:p52756]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.957\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1491\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucose-6-phosphate isomerase (ec 5.3.1.9) (gpi) (phosphoglucose isomerase) (pgi) (phosphohexose isomerase) (phi) (neuroleukin) (nlk) (sperm antigen-36) (sa-36). [source:swissprot;acc:p06744]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.704\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.839\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01899\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
116.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.654\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.944\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1492\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec5. [source:swissprot;acc:q96kp1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
116.771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.707\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.936\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
opioid binding protein/cell adhesion molecule precursor (obcam) (opioid-binding cell adhesion molecule) (opcml). [source:swissprot;acc:q14982]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.017\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01883\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1493\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
204.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.988\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01882\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uridine kinase-like 1. [source:swissprot;acc:q9nwz5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.084\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.149\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.935\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1494\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
116.845\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.772\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.927\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, somatic form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type i). [source:swissprot;acc:p08559]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.967\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01878\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1495\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
229.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01874\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.516\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.916\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1496\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01874\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.838\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.889\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1497\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
exportin 1; exportin-1 (required for chromosome region maintenance); exportin 1 (crm1, yeast, homolog); crm1, yeast, homolog. [source:refseq;acc:nm\_003400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.476\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01866\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
j kappa-recombination signal binding protein (rbp-j kappa). [source:swissprot;acc:q06330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.888\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1498\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer binding protein 3. [source:refseq;acc:nm\_024503]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurotrimin precursor (hnt). [source:swissprot;acc:q9p121]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.924\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1499\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor smif; decapping enzyme hdcp1a. [source:refseq;acc:nm\_018403]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
224.509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.411\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01859\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 40 (human immunodeficiency virus type i enhancer- binding protein 1) (hiv-ep1) (major histocompatibility complex binding protein 1) (mbp-1) (positive regulatory domain ii binding factor 1) (prdii-bf1). [source:swissprot;acc:p15822]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.888\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1500\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 complex subunit 4; likely ortholog of mouse cop9 (constitutive photomorphogenic), subunit 4 (arabidopsis); cop9 (constitutive photomorphogenic, arabidopsis, homolog) subunit 4. [source:refseq;acc:nm\_016129]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.398\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01851\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer-binding protein 2 (hiv-ep2). [source:swissprot;acc:p31629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.888\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/